financetom
Business
financetom
/
Business
/
Nrg Energy Insider Sold Shares Worth $5,484,600, According to a Recent SEC Filing
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Nrg Energy Insider Sold Shares Worth $5,484,600, According to a Recent SEC Filing
Jan 6, 2025 2:26 PM

05:10 PM EST, 01/06/2025 (MT Newswires) -- Robert J Gaudette, Executive Vice President, NRG Business, on January 02, 2025, sold 60,000 shares in Nrg Energy ( NRG ) for $5,484,600. Following the Form 4 filing with the SEC, Gaudette has control over a total of 64,448 shares of the company, with 64,448 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1013871/000122520825000390/xslF345X05/doc4.xml

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Google agrees $36 million fine for anti-competitive deals with Australia telcos
Aug 17, 2025
SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...
Merck Says FDA Accepts for Review New Drug Application for Doravirine/Islatravir to Treat HIV-1 Infection in Adults
Merck Says FDA Accepts for Review New Drug Application for Doravirine/Islatravir to Treat HIV-1 Infection in Adults
Jul 10, 2025
07:21 AM EDT, 07/10/2025 (MT Newswires) -- Merck ( MRK ) said Thursday the US Food and Drug Administration has accepted for review the new drug application for doravirine/islatravir, intended for adults with a certain HIV-1 infection. The FDA has set a target action date of April 28, 2026. The application is based on findings of two phase 3 studies...
Trilogy Metals Q2 Comprehensive Loss Widens
Trilogy Metals Q2 Comprehensive Loss Widens
Jul 10, 2025
07:18 AM EDT, 07/10/2025 (MT Newswires) -- Trilogy Metals ( TMQ ) on Thursday said its second-quarter comprehensive loss widened due to higher regulatory expenses and legal fees related to its base shelf prospectus and at-the-market equity program. The comprehensive loss came in at US$2.2 million, or US$0.01 per share, compared with a loss of US$1.8 million, or US$0.01 per...
Volatus Aerospace Announces Non-Brokered LIFE Financing of up to $10 Million
Volatus Aerospace Announces Non-Brokered LIFE Financing of up to $10 Million
Jul 10, 2025
07:20 AM EDT, 07/10/2025 (MT Newswires) -- Volatus Aerospace ( TAKOF ) overnight Wednesday said it filed an offering document in connection with a non-brokered private placement for gross proceeds of up to $10 million. The LIFE financing includes up to around 19.2 million units of the company at a price of $0.52 each. Each unit will be made up...
Copyright 2023-2026 - www.financetom.com All Rights Reserved